Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma

Evaluation based on data from 1450 patients

Tamar Tadmor, Alessia Bari, Luigi Marcheselli, Stefano Sacchi, Ariel Aviv, Luca Baldini, Paolo G. Gobbi, Samantha Pozzi, Paola Ferri, Maria Christina Cox, Nicola Cascavilla, Emilio Iannitto, Massimo Federico, Aaron Polliack

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective To verify whether absolute monocyte count (AMC) and lymphocyte- monocyte ratio (LMR) at diagnosis are valid prognostic parameters in classical Hodgkin lymphoma (cHL). Patients and Methods Data were collected from 1450 patients with cHL treated in Israel and Italy from January 1, 1988, through December 31, 2007. Results The median age of the patients was 33 years (range, 17-72 years), and 70% (1017) of the patients had nodular sclerosis (NS); the median follow-up duration was 87 months. The best cutoff value for AMC was 750 cells/mm3, and the best ratio for LMR was 2.1. The adverse prognostic impact of an AMC of more than 750 cells/mm3 was confirmed for the entire cohort, and its clinical significance was particularly evident in patients with NS histology. The progression-free survival (PFS) at 10 years for an AMC of more than 750 cells/mm3 was 65% (56%-72%), and the PFS at 10 years for an AMC of 750 cells/mm3 or less was 81% (76%-84%; P3 was 78% (70%-85%), and the OS at 10 years for an AMC of 750 cells/mm3 or less was 88% (84%-90%; P=.01). In multivariate analysis, both AMC and LMR maintained prognostic significance for PFS (hazard ratio [HR], 1.54, P=.006, and HR, 1.50, P=.006) after adjusting for the international prognostic score, whereas the impact on OS was confirmed (HR, 1.56; P=.04) only in patients with NS and an AMC of more than 750 cells/mm3. Conclusion This study confirms that AMC has prognostic value in cHL that is particularly significant in patients with NS subtype histology. This finding links the known impact of macrophages and monocytes in Hodgkin lymphoma with routine clinical practice.

Original languageEnglish
Pages (from-to)756-764
Number of pages9
JournalMayo Clinic Proceedings
Volume90
Issue number6
DOIs
Publication statusPublished - Jun 1 2015

Fingerprint

Lymphocyte Count
Sclerosis
Hodgkin Disease
Monocytes
Disease-Free Survival
Histology
Cell Count
Israel
Italy
Multivariate Analysis
Macrophages

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma : Evaluation based on data from 1450 patients. / Tadmor, Tamar; Bari, Alessia; Marcheselli, Luigi; Sacchi, Stefano; Aviv, Ariel; Baldini, Luca; Gobbi, Paolo G.; Pozzi, Samantha; Ferri, Paola; Cox, Maria Christina; Cascavilla, Nicola; Iannitto, Emilio; Federico, Massimo; Polliack, Aaron.

In: Mayo Clinic Proceedings, Vol. 90, No. 6, 01.06.2015, p. 756-764.

Research output: Contribution to journalArticle

Tadmor, Tamar ; Bari, Alessia ; Marcheselli, Luigi ; Sacchi, Stefano ; Aviv, Ariel ; Baldini, Luca ; Gobbi, Paolo G. ; Pozzi, Samantha ; Ferri, Paola ; Cox, Maria Christina ; Cascavilla, Nicola ; Iannitto, Emilio ; Federico, Massimo ; Polliack, Aaron. / Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma : Evaluation based on data from 1450 patients. In: Mayo Clinic Proceedings. 2015 ; Vol. 90, No. 6. pp. 756-764.
@article{d1ae27b5244a4f638e4a46e92a7cb18f,
title = "Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: Evaluation based on data from 1450 patients",
abstract = "Objective To verify whether absolute monocyte count (AMC) and lymphocyte- monocyte ratio (LMR) at diagnosis are valid prognostic parameters in classical Hodgkin lymphoma (cHL). Patients and Methods Data were collected from 1450 patients with cHL treated in Israel and Italy from January 1, 1988, through December 31, 2007. Results The median age of the patients was 33 years (range, 17-72 years), and 70{\%} (1017) of the patients had nodular sclerosis (NS); the median follow-up duration was 87 months. The best cutoff value for AMC was 750 cells/mm3, and the best ratio for LMR was 2.1. The adverse prognostic impact of an AMC of more than 750 cells/mm3 was confirmed for the entire cohort, and its clinical significance was particularly evident in patients with NS histology. The progression-free survival (PFS) at 10 years for an AMC of more than 750 cells/mm3 was 65{\%} (56{\%}-72{\%}), and the PFS at 10 years for an AMC of 750 cells/mm3 or less was 81{\%} (76{\%}-84{\%}; P3 was 78{\%} (70{\%}-85{\%}), and the OS at 10 years for an AMC of 750 cells/mm3 or less was 88{\%} (84{\%}-90{\%}; P=.01). In multivariate analysis, both AMC and LMR maintained prognostic significance for PFS (hazard ratio [HR], 1.54, P=.006, and HR, 1.50, P=.006) after adjusting for the international prognostic score, whereas the impact on OS was confirmed (HR, 1.56; P=.04) only in patients with NS and an AMC of more than 750 cells/mm3. Conclusion This study confirms that AMC has prognostic value in cHL that is particularly significant in patients with NS subtype histology. This finding links the known impact of macrophages and monocytes in Hodgkin lymphoma with routine clinical practice.",
author = "Tamar Tadmor and Alessia Bari and Luigi Marcheselli and Stefano Sacchi and Ariel Aviv and Luca Baldini and Gobbi, {Paolo G.} and Samantha Pozzi and Paola Ferri and Cox, {Maria Christina} and Nicola Cascavilla and Emilio Iannitto and Massimo Federico and Aaron Polliack",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.mayocp.2015.03.025",
language = "English",
volume = "90",
pages = "756--764",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "6",

}

TY - JOUR

T1 - Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma

T2 - Evaluation based on data from 1450 patients

AU - Tadmor, Tamar

AU - Bari, Alessia

AU - Marcheselli, Luigi

AU - Sacchi, Stefano

AU - Aviv, Ariel

AU - Baldini, Luca

AU - Gobbi, Paolo G.

AU - Pozzi, Samantha

AU - Ferri, Paola

AU - Cox, Maria Christina

AU - Cascavilla, Nicola

AU - Iannitto, Emilio

AU - Federico, Massimo

AU - Polliack, Aaron

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Objective To verify whether absolute monocyte count (AMC) and lymphocyte- monocyte ratio (LMR) at diagnosis are valid prognostic parameters in classical Hodgkin lymphoma (cHL). Patients and Methods Data were collected from 1450 patients with cHL treated in Israel and Italy from January 1, 1988, through December 31, 2007. Results The median age of the patients was 33 years (range, 17-72 years), and 70% (1017) of the patients had nodular sclerosis (NS); the median follow-up duration was 87 months. The best cutoff value for AMC was 750 cells/mm3, and the best ratio for LMR was 2.1. The adverse prognostic impact of an AMC of more than 750 cells/mm3 was confirmed for the entire cohort, and its clinical significance was particularly evident in patients with NS histology. The progression-free survival (PFS) at 10 years for an AMC of more than 750 cells/mm3 was 65% (56%-72%), and the PFS at 10 years for an AMC of 750 cells/mm3 or less was 81% (76%-84%; P3 was 78% (70%-85%), and the OS at 10 years for an AMC of 750 cells/mm3 or less was 88% (84%-90%; P=.01). In multivariate analysis, both AMC and LMR maintained prognostic significance for PFS (hazard ratio [HR], 1.54, P=.006, and HR, 1.50, P=.006) after adjusting for the international prognostic score, whereas the impact on OS was confirmed (HR, 1.56; P=.04) only in patients with NS and an AMC of more than 750 cells/mm3. Conclusion This study confirms that AMC has prognostic value in cHL that is particularly significant in patients with NS subtype histology. This finding links the known impact of macrophages and monocytes in Hodgkin lymphoma with routine clinical practice.

AB - Objective To verify whether absolute monocyte count (AMC) and lymphocyte- monocyte ratio (LMR) at diagnosis are valid prognostic parameters in classical Hodgkin lymphoma (cHL). Patients and Methods Data were collected from 1450 patients with cHL treated in Israel and Italy from January 1, 1988, through December 31, 2007. Results The median age of the patients was 33 years (range, 17-72 years), and 70% (1017) of the patients had nodular sclerosis (NS); the median follow-up duration was 87 months. The best cutoff value for AMC was 750 cells/mm3, and the best ratio for LMR was 2.1. The adverse prognostic impact of an AMC of more than 750 cells/mm3 was confirmed for the entire cohort, and its clinical significance was particularly evident in patients with NS histology. The progression-free survival (PFS) at 10 years for an AMC of more than 750 cells/mm3 was 65% (56%-72%), and the PFS at 10 years for an AMC of 750 cells/mm3 or less was 81% (76%-84%; P3 was 78% (70%-85%), and the OS at 10 years for an AMC of 750 cells/mm3 or less was 88% (84%-90%; P=.01). In multivariate analysis, both AMC and LMR maintained prognostic significance for PFS (hazard ratio [HR], 1.54, P=.006, and HR, 1.50, P=.006) after adjusting for the international prognostic score, whereas the impact on OS was confirmed (HR, 1.56; P=.04) only in patients with NS and an AMC of more than 750 cells/mm3. Conclusion This study confirms that AMC has prognostic value in cHL that is particularly significant in patients with NS subtype histology. This finding links the known impact of macrophages and monocytes in Hodgkin lymphoma with routine clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=84931003455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931003455&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2015.03.025

DO - 10.1016/j.mayocp.2015.03.025

M3 - Article

VL - 90

SP - 756

EP - 764

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 6

ER -